YoshikawaKazunori

Veneno Technologies will participate in Kansai Bio Business Matching 2022. On the day of the event, Dr. Matsukawa, Director, will make a pitch introducing our […]

Veneno Technologies will participate in the 13th annual meeting of Conference on Biomolecular Screenology (Funabori, Tokyo). Dr. Taira, Director, will give a poster presentation at […]

Veneno Technologies will participate in BIO-Europoe 2022 (Online), one of Europe’s largest business matching events in the biotechnology field (drug discovery, drug discovery support, regenerative […]

Veneno Technologies will participate in BRAVE GLOBAL, an overseas networking and global expansion event hosted by Beyond Next Venture (OIST, Okinawa, Japan).

Veneno T echnologies will participate in the 17th Annual Peptide Therapeutics Symposium (Salk Institute, San Diego). Dr. Taira, Director, will give a poster presentation at […]

Veneno Technologies will exhibit at JHCVS hosted by the Ministry of Health, Labor and Welfare, which will be held in conjunction with BioJapan at Pacifico […]

Veneno Technologies published a technical article in the August issue of the scientific journal AgreBio, entitled “Veneno Suite,” the Most Advanced Disulfide Rich Peptide Screening […]

Veneno Technologies will exhibit at the 2022 BIO International Convention in San Diego as a company selected for the JETRO Overseas Operations Support Program.

Veneno Technoloiges will participate the 14th Australian Peptide Conference to be held in Gold Coast, Australia to be held in Gold Coast, Australia.Dr. Taira, Director, […]

Veneno Technologies is introduced as a bio-venture that provides a new drug discovery platform based on research on tarantula venom at AIST (The National Institute […]